South and Central America Clinical Trials Supplies Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product & Service (Manufacturing, Packaging & Labelling, and Logistics & Distribution), Stage (Phase I, Phase II, Phase III, and Bioequivalence Studies), Drug Type (Small-Molecule Drugs and Biologic Drugs), and Application (Oncology, Cardiovascular Diseases, Neurological Disorders, Respiratory Disorders, and Others)

No. of Pages: 122    |    Report Code: TIPRE00022068    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South and Central America Clinical Trials Supplies Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. South and Central America Clinical Trials Supplies Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. South and Central America Clinical Trials Supplies Market – Key Market Dynamics

5.1 Growth Drivers
5.2 Market Opportunities
5.3 Future Trends
5.4 Impact of Drivers and Restraints

6. South and Central America Clinical Trials Supplies Market Regional Analysis

6.1 South and Central America Clinical Trials Supplies Market Overview
6.2 South and Central America Clinical Trials Supplies Market Revenue 2017-2027 (US$ Million)
6.3 South and Central America Clinical Trials Supplies Market Forecast Analysis

7. South and Central America Clinical Trials Supplies Market Analysis – by Product & Service

7.1 Manufacturing
  • 7.1.1 Overview
  • 7.1.2 Manufacturing: South and Central America Clinical Trials Supplies Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Packaging & Labelling
  • 7.2.1 Overview
  • 7.2.2 Packaging & Labelling: South and Central America Clinical Trials Supplies Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Logistics & Distribution
  • 7.3.1 Overview
  • 7.3.2 Logistics & Distribution: South and Central America Clinical Trials Supplies Market – Revenue and Forecast to 2031 (US$ Million)

8. South and Central America Clinical Trials Supplies Market Analysis – by Stage

8.1 Phase I
  • 8.1.1 Overview
  • 8.1.2 Phase I: South and Central America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Phase II
  • 8.2.1 Overview
  • 8.2.2 Phase II: South and Central America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Phase III
  • 8.3.1 Overview
  • 8.3.2 Phase III: South and Central America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Bioequivalence Studies
  • 8.4.1 Overview
  • 8.4.2 Bioequivalence Studies: South and Central America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)

9. South and Central America Clinical Trials Supplies Market Analysis – by Drug Type

9.1 Small-Molecule Drugs
  • 9.1.1 Overview
  • 9.1.2 Bioequivalence Studies: South and Central America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Biologic Drugs
  • 9.2.1 Overview
  • 9.2.2 Bioequivalence Studies: South and Central America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)

10. South and Central America Clinical Trials Supplies Market – South and Central America Analysis

10.1 South and Central America
  • 10.1.1 South and Central America Clinical Trials Supplies Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.1.1.1 South and Central America Clinical Trials Supplies Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 Brazil: South and Central America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 Brazil: South and Central America Clinical Trials Supplies Market Breakdown, by Product & Service
    • 10.1.1.1.2 Brazil: South and Central America Clinical Trials Supplies Market Breakdown, by Stage
    • 10.1.1.1.3 Brazil: South and Central America Clinical Trials Supplies Market Breakdown, by Drug Type
  • 10.1.1.2 Argentina: South and Central America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 Argentina: South and Central America Clinical Trials Supplies Market Breakdown, by Product & Service
    • 10.1.1.2.2 Argentina: South and Central America Clinical Trials Supplies Market Breakdown, by Stage
    • 10.1.1.2.3 Argentina: South and Central America Clinical Trials Supplies Market Breakdown, by Drug Type
  • 10.1.1.3 Rest of South and Central America : South and Central America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 Rest of South and Central America : South and Central America Clinical Trials Supplies Market Breakdown, by Product & Service
    • 10.1.1.3.2 Rest of South and Central America : South and Central America Clinical Trials Supplies Market Breakdown, by Stage
    • 10.1.1.3.3 Rest of South and Central America : South and Central America Clinical Trials Supplies Market Breakdown, by Drug Type

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. South and Central America Clinical Trials Supplies Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 UDG Healthcare plc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Catalent Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 pci Pharma Services
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 PAREXEL INTERNATIONAL CORPORATION
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Biocair
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Owens & Minor Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - South and Central America Clinical Trials Supplies Market

  1. THERMO FISHER SCIENTIFIC INC.
  2. UDG Healthcare plc
  3. Catalent Inc.
  4. pci Pharma Services
  5. PAREXEL INTERNATIONAL CORPORATION
  6. Biocair
  7. Owens & Minor Inc
south-and-central-america-clinical-trials-supplies-market